152 related articles for article (PubMed ID: 11336796)
21. The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt.
Gómez del Pulgar T; Velasco G; Guzmán M
Biochem J; 2000 Apr; 347(Pt 2):369-73. PubMed ID: 10749665
[TBL] [Abstract][Full Text] [Related]
22. Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats.
Morera-Herreras T; Ruiz-Ortega JA; Linazasoro G; Ugedo L
Psychopharmacology (Berl); 2011 Mar; 214(2):379-89. PubMed ID: 20959968
[TBL] [Abstract][Full Text] [Related]
23. Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration.
Anikwue R; Huffman JW; Martin ZL; Welch SP
J Pharmacol Exp Ther; 2002 Oct; 303(1):340-6. PubMed ID: 12235269
[TBL] [Abstract][Full Text] [Related]
24. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].
Shivachar AC; Martin BR; Ellis EF
Biochem Pharmacol; 1996 Mar; 51(5):669-76. PubMed ID: 8615904
[TBL] [Abstract][Full Text] [Related]
25. Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors.
Lambert DM; DiPaolo FG; Sonveaux P; Kanyonyo M; Govaerts SJ; Hermans E; Bueb J; Delzenne NM; Tschirhart EJ
Biochim Biophys Acta; 1999 Sep; 1440(2-3):266-74. PubMed ID: 10521710
[TBL] [Abstract][Full Text] [Related]
26. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
Breivogel CS; Griffin G; Di Marzo V; Martin BR
Mol Pharmacol; 2001 Jul; 60(1):155-63. PubMed ID: 11408610
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.
Makwana R; Molleman A; Parsons ME
Br J Pharmacol; 2010 Apr; 159(8):1608-22. PubMed ID: 20233228
[TBL] [Abstract][Full Text] [Related]
28. Effect of cannabinoids on platelet serotonin uptake.
Velenovská M; Fisar Z
Addict Biol; 2007 Jun; 12(2):158-66. PubMed ID: 17508987
[TBL] [Abstract][Full Text] [Related]
29. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid-induced changes in respiration of brain mitochondria.
Fišar Z; Singh N; Hroudová J
Toxicol Lett; 2014 Nov; 231(1):62-71. PubMed ID: 25195527
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
Lay L; Angus JA; Wright CE
Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
[TBL] [Abstract][Full Text] [Related]
32. Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland.
González S; Bisogno T; Wenger T; Manzanares J; Milone A; Berrendero F; Di Marzo V; Ramos JA; Fernández-Ruiz JJ
Biochem Biophys Res Commun; 2000 Apr; 270(1):260-6. PubMed ID: 10733937
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors.
Scutt A; Williamson EM
Calcif Tissue Int; 2007 Jan; 80(1):50-9. PubMed ID: 17205329
[TBL] [Abstract][Full Text] [Related]
34. Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists delta9-THC, WIN 55,212-2 and anandamide in mice.
Raffa RB; Stone DJ; Hipp SJ
Neurosci Lett; 1999 Mar; 263(1):29-32. PubMed ID: 10218903
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
Shivachar AC
Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism.
Sun Y; Alexander SP; Garle MJ; Gibson CL; Hewitt K; Murphy SP; Kendall DA; Bennett AJ
Br J Pharmacol; 2007 Nov; 152(5):734-43. PubMed ID: 17906680
[TBL] [Abstract][Full Text] [Related]
37. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
38. Differential stimulatory effects of cannabinoids on VIP release and NO synthase activity in synaptosomal fractions from rat ileum.
Kurjak M; Hamel AM; Allescher HD; Schusdziarra V; Storr M
Neuropeptides; 2008; 42(5-6):623-32. PubMed ID: 18829105
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat.
Helyes Z; Németh J; Thán M; Bölcskei K; Pintér E; Szolcsányi J
Life Sci; 2003 Sep; 73(18):2345-53. PubMed ID: 12941436
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.
McMahon LR; Ginsburg BC; Lamb RJ
Psychopharmacology (Berl); 2008 Jul; 198(4):487-95. PubMed ID: 17673980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
